Butylone On Sale


From: 135.00$ From: 115.00$

Methylone, also known as “M1”, 3,4-methylenedioxy-N-methylcathinone, and bk-MDMA is an entactogen (class of psychoactive drugs that produce distinctive emotional and social effects similar to those of MDMA(ecstasy)) and stimulant of the amphetamine,



Butylone,  also known as β-keto-N-methylbenzodioxolylbutanamine, is an entactogen, psychedelic, and stimulant psychoactive drug of the phenethylamine chemical class. Butylone was first synthesized by Koeppe, Ludwig, and Zeile in 1967. It remained an obscure product of academia until 2005

Butylone can be synthesized in a laboratory via the following route: 3,4-methylenedioxybutyrophenone dissolved in dichloromethane to bromine gives 3′,4′-methylenedioxy-2-bromobutyrophenone. This product was then dissolved in dichloromethane and added to an aqueous solution of methylamine (40%). HCl was then added. The aqueous layer was removed and made alkaline by using sodium bicarbonate. For the extraction of the amine ether was used. To get butylone a drop of ether and HCl solution was added

Butylone acts in a similar way as MDMA and Methylone, it causes an increase in extracellular monoamine levels
Butylone was first synthesized by Koeppe, Ludwig and Zeile which is mentioned in their 1967 paper. It remained an obscure product of academia until 2005 when it was sold as a designer drug.[1] Butylone shares the same relationship to MBDB as methylone does to MDMA (“Ecstasy”). Formal research on this chemical was first conducted in 2009, when it was shown to be metabolised in a similar manner to related drugs like methylone
Butylone, also known as β-keto-N-methylbenzodioxolylbutanamine (βk-MBDB), is an entactogen, psychedelic, and stimulant psychoactive drug of the phenethylamine chemical class. It is the β-keto (substituted cathinone) analogue of MBDB and the substituted methylenedioxyphenethylamine analogue of buphedrone

There are three major metabolic pathways of bk-MBDB as shown in the figure. As result of demethylenation followed by O-methylation bk-MBDB metabolises into 4-OH-3-MeO and 3-OH-4-MeO metabolites in human urine. The second pathway is a β-ketone reduction into β-ketone reduced metabolites. The third pathway is a N-dealkylation into N-dealkyl metabolites. The first two pathways occur more than pathway three. The most common metabolite is the 4-OH-3-MeO metabolite. The metabolites containing a hydroxyl-group would be excreted as their conjugates in urine

6 reviews for this item

  1. 2 out of 5

    customer service very helpful and replied to all my questions on time.Everything went well with me here and i received my order 2 times i buy from here . i appreciate their services and product

  2. 5 out of 5

    I was referred to this company by a friend and since then i have been buying Butylone from them with excellent quality. I have found my true and real supplier with this company. 100% Recommendable.

  3. 5 out of 5

    Received but not in the morning instead of yesterday evening.. Nevertheless you made my day with your excellent quality.

  4. 5 out of 5

    Butylone crystals i received was great. and i plan to try MDMA in next order next week. GREAT services

  5. 5 out of 5

    Received all my packages. ordered 6 times and all perfect. This company is real and legit and product quality the best i have received so far with other companies.

  6. 5 out of 5

    Received my order %%%%%%%%%%%%%%

Add your review